- Filed
- Dec 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2026 · Oct 31, 2025 | 472.61M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2025 | 472.72M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2024 | 473.06M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2024 | 473M sh |
| Stock Repurchased | Q2 2026 · Oct 31, 2025 | $99M |
| Stock Repurchased | Q2 2026 · Oct 31, 2024 | $0 |
| Dividends Paid | Q2 2026 · Oct 31, 2025 | $214M |
| Dividends Paid | Q2 2026 · Oct 31, 2024 | $206M |
| Capex | Q2 2026 · Oct 31, 2025 | $56M |
| Capex | Q2 2026 · Oct 31, 2024 | $72M |
| Operating Cash Flow | Q2 2026 · Oct 31, 2025 | $292M |
| Operating Cash Flow | Q2 2026 · Oct 31, 2024 | $129M |
| Long Term Debt | Q2 2026 · Oct 31, 2025 | $2.07B |
| Long Term Debt | Q2 2026 · Apr 30, 2025 | $2.42B |
| Short Term Debt | Q2 2026 · Oct 31, 2025 | $228M |
| Short Term Debt | Q2 2026 · Apr 30, 2025 | $312M |
| Cash And Equivalents | Q2 2026 · Oct 31, 2025 | $319M |
| Cash And Equivalents | Q2 2026 · Apr 30, 2025 | $444M |
| Cash And Equivalents | Q2 2026 · Oct 31, 2024 | $416M |
| Stockholders Equity | Q2 2026 · Oct 31, 2025 | $4.13B |
| Stockholders Equity | Q2 2026 · Jul 31, 2025 | $3.99B |
| Stockholders Equity | Q2 2026 · Apr 30, 2025 | $3.99B |
| Stockholders Equity | Q2 2026 · Oct 31, 2024 | $3.71B |
| Stockholders Equity | Q2 2026 · Jul 31, 2024 | $3.47B |
| Stockholders Equity | Q2 2026 · Apr 30, 2024 | $3.52B |
| Current Liabilities | Q2 2026 · Oct 31, 2025 | $1.42B |
| Current Liabilities | Q2 2026 · Apr 30, 2025 | $1.08B |
| Total Liabilities | Q2 2026 · Oct 31, 2025 | $4.09B |
| Total Liabilities | Q2 2026 · Apr 30, 2025 | $4.09B |
| Current Assets | Q2 2026 · Oct 31, 2025 | $4.21B |
| Current Assets | Q2 2026 · Apr 30, 2025 | $4.2B |
| Total Assets | Q2 2026 · Oct 31, 2025 | $8.22B |
| Total Assets | Q2 2026 · Apr 30, 2025 | $8.09B |
| Eps Diluted | Q2 2026 · Oct 31, 2025 | $0.47 |
| Eps Diluted | Q2 2026 · Oct 31, 2025 | $0.83 |
| Eps Diluted | Q2 2026 · Oct 31, 2024 | $0.55 |
| Eps Diluted | Q2 2026 · Oct 31, 2024 | $0.96 |
| Eps Basic | Q2 2026 · Oct 31, 2025 | $0.47 |
| Eps Basic | Q2 2026 · Oct 31, 2025 | $0.83 |
| Eps Basic | Q2 2026 · Oct 31, 2024 | $0.55 |
| Eps Basic | Q2 2026 · Oct 31, 2024 | $0.96 |
| Sga Expense | Q2 2026 · Oct 31, 2025 | $187M |
| Sga Expense | Q2 2026 · Oct 31, 2025 | $364M |
| Sga Expense restated | Q2 2026 · Oct 31, 2024 | $185M |
| Sga Expense restated | Q2 2026 · Oct 31, 2024 | $373M |
| Net Income | Q2 2026 · Oct 31, 2025 | $224M |
| Net Income | Q2 2026 · Oct 31, 2025 | $394M |
| Net Income | Q2 2026 · Jul 31, 2025 | $170M |
| Net Income | Q2 2026 · Oct 31, 2024 | $258M |
| Net Income | Q2 2026 · Oct 31, 2024 | $453M |
| Net Income | Q2 2026 · Jul 31, 2024 | $195M |
| Operating Income | Q2 2026 · Oct 31, 2025 | $305M |
| Operating Income | Q2 2026 · Oct 31, 2025 | $565M |
| Operating Income | Q2 2026 · Oct 31, 2024 | $341M |
| Operating Income | Q2 2026 · Oct 31, 2024 | $622M |
| Gross Profit | Q2 2026 · Oct 31, 2025 | $615M |
| Gross Profit | Q2 2026 · Oct 31, 2025 | $1.17B |
| Gross Profit | Q2 2026 · Oct 31, 2024 | $646M |
| Gross Profit | Q2 2026 · Oct 31, 2024 | $1.21B |
| Cost Of Revenue | Q2 2026 · Oct 31, 2025 | $421M |
| Cost Of Revenue | Q2 2026 · Oct 31, 2025 | $793M |
| Cost Of Revenue | Q2 2026 · Oct 31, 2024 | $449M |
| Cost Of Revenue | Q2 2026 · Oct 31, 2024 | $835M |
| Revenue | Q2 2026 · Oct 31, 2025 | $1.04B |
| Revenue | Q2 2026 · Oct 31, 2025 | $1.96B |
| Revenue | Q2 2026 · Oct 31, 2024 | $1.1B |
| Revenue | Q2 2026 · Oct 31, 2024 | $2.05B |